We are live on ! Find out more
TM

Tikvah Management Portfolio holdings

AUM $323M
1-Year Est. Return 69.61%
This Fund
S&P 500
This Quarter Est. Return
+1.14%
1 Year Est. Return
+69.61%
3 Year Est. Return
+173.03%
5 Year Est. Return
+103.33%
10 Year Est. Return
+586.01%
AUM
$142M
AUM Growth
+$6.86M
Cap. Flow
+$4.41M
Cap. Flow %
3.1%
Top 10 Hldgs %
90.76%
Holding
18
New
1
Increased
4
Reduced
1
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 27.06%
2 Financials 22.64%
3 Healthcare 8.02%
4 Communication Services 5.48%
5 Consumer Staples 1.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$37.6M 26.48%
192,214
NATI
2
DELISTED
National Instruments Corp
NATI
$13.1M 9.23%
405,000
BRK.A icon
3
Berkshire Hathaway Class A
BRK.A
$1.1T
$12.9M 9.09%
68
BIO.B icon
4
Bio-Rad Laboratories Class B
BIO.B
$11.4M 8.02%
+95,197
New +$11.7M
NICE icon
5
Nice
NICE
$5.79B
$9.44M 6.64%
231,250
+44,000
+23% +$1.82M
GS icon
6
Goldman Sachs
GS
$300B
$9.31M 6.55%
55,591
BAC icon
7
Bank of America
BAC
$435B
$9.24M 6.51%
601,527
QADA
8
DELISTED
QAD Inc.
QADA
$9.07M 6.38%
425,376
+184,106
+76% +$3.76M
QGENF
9
DELISTED
QIAGEN NV
QGENF
$9.03M 6.36%
369,425
GOOG icon
10
Alphabet (Google) Class C
GOOG
$4.36T
$7.79M 5.48%
269,458
+33,858
+14% +$919K
GUID
11
DELISTED
Guidance Software, Inc.
GUID
$4.24M 2.98%
464,314
-5,945
-1% -$56.5K
BRLI
12
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$3.48M 2.45%
115,000
CPLA
13
DELISTED
Capella Education Company
CPLA
$2.14M 1.51%
39,416
QADB
14
DELISTED
QAD Inc. Class B
QADB
$1.42M 1%
78,398
+1,302
+2% +$22.4K
ASML icon
15
ASML
ASML
$626B
$1.16M 0.82%
12,450
LPLA icon
16
LPL Financial
LPLA
$28.3B
$687K 0.48%
13,812
BIO icon
17
Bio-Rad Laboratories Class A
BIO
$8.71B
-95,197
Closed -$12.2M
ACCL
18
DELISTED
Accelrys Inc
ACCL
-122,935
Closed -$1.53M

Similar funds

Tikvah Management's Q2 2014 Portfolio in Review

As of Q2 2014, Tikvah Management held 18 positions worth $142M, up 5.1% from $135M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Tikvah Management deployed $4.41M of net new capital in Q2 2014, opening 1 new position and adding to 4 existing holdings. Its largest new stake was Bio-Rad Laboratories Class B: 95,197 shares worth $11.4M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Guidance Software, Inc., an estimated $56.5K trimmed.

  • Tikvah Management's largest Q2 2014 buy was Bio-Rad Laboratories Class B: 95,197 shares worth $11.4M.
  • Tikvah Management added most to QAD Inc. in Q2 2014, an estimated $3.76M increase.
  • Tikvah Management's biggest Q2 2014 reduction was Guidance Software, Inc., cutting an estimated $56.5K.
  • Tikvah Management fully exited Bio-Rad Laboratories Class A in Q2 2014, selling an estimated $12.2M.
  • Tikvah Management's ten largest holdings make up 91% of its $142M portfolio in Q2 2014.
  • Tikvah Management opened 1 new position and closed 2 in Q2 2014.
  • Tikvah Management's portfolio value rose 5.1% quarter-over-quarter to $142M.

Based on Tikvah Management's 13F filing for Q2 2014, filed 14 Aug 2014.